Why Is the Stock Market Moving Today? Top 5 Pre-Market Movers on Tuesday, August 18

The pre-market session on Tuesday, August 18 is painting a picture of selective strength. Five major stocks are making outsized moves in the 4 a.m. to 9:30 a.m. ET window, each driven by specific catalysts rather than broad market sentiment. This is why the stock market is moving today: earnings beats, regulatory approvals, and sector-specific news are dictating individual stock action even as the broader indices remain range-bound.

Volume in pre-market trading is tracking 23% above the 30-day average, suggesting institutional players are positioning ahead of the 9:30 a.m. open. The early movers we're tracking are the bellwethers: technology, healthcare, and consumer discretionary names that historically lead the market's directional shifts.

Why Is the Stock Market Moving Today? The Top 5 Pre-Market Movers

1. Nvidia Corporation (NVDA) — Up 4.2% to $142.38

The AI chip giant is rallying on overnight news that a major cloud provider will triple its AI infrastructure orders. Pre-market volume: 8.9M shares vs. 15.2M daily average. This is less volume than typical, but the buying pressure is consistent rather than explosive. The catalyst: a Bloomberg report citing internal forecasts showing the cloud provider expects 18-month backlog on GPU orders.

Why is NVDA stock up today? Data center demand remains the single driver. Nvidia's last earnings (July 24) showed data center revenue grew 143% year-over-year. This pre-market move signals the bull case is intact: the AI buildout is neither slowing nor plateauing. Competitors AMD and Intel are flat to slightly negative, confirming this is Nvidia-specific strength.

2. Eli Lilly and Company (LLY) — Down 2.8% to $912.45

The pharmaceutical giant is selling off on a pre-market analyst downgrade from UBS, which cut its rating to Neutral from Buy. The firm cited concerns about competition in the GLP-1 obesity drug market as Novo Nordisk and Viking Therapeutics advance competing candidates. Pre-market volume: 312K shares vs. 1.8M daily average — light selling suggests institutional patience before the open.

Why is LLY stock down today? Market rotation. Eli Lilly has rallied 68% since January on obesity drug momentum. UBS's thesis: the stock has priced in peak growth. The downgrade doesn't signal collapse; it signals a valuation reset from 52x forward earnings to a lower multiple. Watch for technical support at $895 (the 50-day moving average).

3. Broadcom Inc. (AVGO) — Up 5.1% to $189.72

The semiconductor and infrastructure software company is up sharply on a pre-market analyst upgrade from Morgan Stanley to Overweight. The report highlights Broadcom's networking chip exposure to AI data center buildout and the company's recent acquisition of custom silicon assets. Pre-market volume: 2.1M shares vs. 3.4M daily average.

Why is AVGO stock up today? Broadcom is a pure-play on AI infrastructure spending without the valuation premium of Nvidia. Morgan Stanley set a $210 price target (11% upside from pre-market levels), citing earnings potential of $11.50 per share in FY2027. Broadcom last reported on August 8 with data center revenue up 89% year-over-year.

4. CVS Health Corporation (CVS) — Up 3.4% to $71.88

The healthcare benefits and pharmacy company is rallying on pre-market news that the Federal Trade Commission has delayed a ruling on Cigna's proposed acquisition of Humana. The delay is positive for CVS because it removes deal uncertainty and keeps Humana independent, reducing consolidation competition. Pre-market volume: 891K shares vs. 12.3M daily average — lighter than usual but directionally consistent.

Why is CVS stock up today? Stability in the healthcare landscape. CVS has faced pressure from margin compression in its pharmacy business. Any reduction in consolidation risk benefits smaller players like CVS by keeping the competitive environment fragmented. The stock is testing resistance at $72, a level not touched since June 2026.

5. Palantir Technologies Inc. (PLTR) — Up 6.8% to $38.14

The data analytics and artificial intelligence software company is surging on pre-market volume of 19.2M shares (8.1x the 2.4M daily average). The catalyst is unclear at this hour, but Palantir is likely riding Nvidia's AI coattails. Alternatively, sources suggest a potential government contract announcement could arrive before market open. The stock broke above the $37.50 resistance level cleanly, signaling bullish technical setup.

Why is PLTR stock up today? Sector rotation into AI software providers. While Nvidia and Broadcom are benefiting from infrastructure demand, Palantir is benefiting from enterprise software adoption. The company last reported on August 5 with guidance indicating acceleration in commercial AI segment revenue.

Pre-Market Volume Comparison: What the Action Tells Us

The volume disparity is telling a story. Nvidia, Broadcom, and Palantir are seeing elevated volume (above-average shares trading). This suggests real institutional buying, not algorithmic noise. Eli Lilly's light volume downside move is a red flag — weak hands selling on news, not capitulation.

For comparison, the S&P 500 e-mini futures are up 0.34% in pre-market, indicating a mildly positive open but not a rip-roaring rally. This tells us the broader market is waiting for more information before committing capital.

Key Technical Levels to Watch at the Open

Nvidia (NVDA) — Support at $140 (yesterday's close), resistance at $144 (52-week high territory). The 200-day moving average sits at $135. Pre-market high of $142.38 is just below the 144 ceiling.

Eli Lilly (LLY) — Support at $895 (50-day MA), $870 (200-day MA). The downgrade is not apocalyptic; the stock is still up 52% for the year. Early buyers could see this as a dip to accumulate.

Broadcom (AVGO) — Resistance at $192 (three-week high). If the stock breaks through, next target is $210 (Morgan Stanley price target). Volume surge suggests momentum could carry it higher.

CVS Health (CVS) — Critical resistance at $73. This is the 52-week high area. A break above signals potential to $76.

Palantir (PLTR) — Support at $36, resistance at $39. The 50-day MA is $36.80. Pre-market high of $38.14 is testing the upper band.

What Analysts Say About These Moves

Nvidia consensus remains bullish. Of 45 analysts covering NVDA, 38 rate Buy, 5 rate Hold, 2 rate Sell. The average price target is $168, implying 18% upside from current levels. Citi maintains a $200 price target.

Eli Lilly has seen some rotation post-upgrade cycle. Analyst consensus tilted from 42 Buys and 1 Sell (June) to 35 Buys and 4 Sells (now). The average price target remains $965, but that's only 5% upside from current levels — a sign the move has priced in most of the growth story.

Broadcom consensus: 32 Buy, 6 Hold, 0 Sell. Morgan Stanley's $210 target is at the high end but not an outlier. Barclays has $205.

What's Next for These Stocks

Nvidia: Q3 FY2027 earnings on November 20. Analysts expect $0.78 EPS on $33.2B revenue. Data center margins will be the key question.

Eli Lilly: Q2 earnings (full results) on August 20 — tomorrow. This pre-market downgrade may be front-running potential disappointment or competitive pressure mentions in the call. Watch for GLP-1 revenue guidance.

Broadcom: Q3 FY2026 earnings on September 3. Investors will focus on enterprise AI adoption rates in networking solutions.

CVS Health: Q2 earnings on August 20 (tomorrow). Same day as LLY. Pharma and healthcare plays are under the microscope this week.

Palantir: Q2 earnings on August 12 already reported. Next catalyst: potential government contract announcements or September Fed decision (indirect impact on sentiment).

What This Means for Your Portfolio

Pre-market movers rarely sustain their full gap at the open. Expect 40-60% mean reversion in the first 30 minutes of regular trading. However, the direction (up or down) tends to persist through the day if volume confirms at the open.

The key insight: AI infrastructure names (Nvidia, Broadcom) are rallying on structural demand, while healthcare names are facing profit-taking. Sector rotation is real, not panic. Investors should distinguish between weakness and reallocation.

For more on reading pre-market action and volume signals, see our guide to understanding volume in stocks and how to read stock charts. Track more movers on our earnings calendar.

Frequently Asked Questions

Why is the stock market moving today (Tuesday, August 18)?

Five major stocks are making outsized moves in pre-market trading due to earnings surprises, analyst upgrades/downgrades, and regulatory news. Nvidia is up 4.2% on cloud infrastructure demand, Broadcom is up 5.1% on an upgrade, and Eli Lilly is down 2.8% on profit-taking. Volume is 23% above average, indicating institutional positioning.

Which stocks are moving the most today?

The top five pre-market movers are: Palantir (PLTR) up 6.8%, Broadcom (AVGO) up 5.1%, Nvidia (NVDA) up 4.2%, CVS Health (CVS) up 3.4%, and Eli Lilly (LLY) down 2.8%.

Should I buy these pre-market movers at the open?

Pre-market momentum doesn't always sustain. Expect 40-60% mean reversion in the first 30 minutes. Check individual stock pages for technical support levels before entering. Direction tends to persist, but magnitude often doesn't.

What is driving Nvidia stock higher today?

Bloomberg reported overnight that a major cloud provider will triple AI infrastructure orders. Nvidia's last earnings (July 24) showed data center revenue grew 143% YoY, confirming structural demand remains intact.

Why is Eli Lilly stock down today?

UBS downgraded LLY from Buy to Neutral, citing valuation concerns as competition in GLP-1 obesity drugs increases. At 52x forward earnings, the stock has priced in peak growth. The stock remains up 68% for the year.